Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Cell-penetrating peptide enhances tafazzin gene therapy in mouse model of barth syndrome
doi: 10.1177/2472555218822098 208 OyamaY.ChikahisaL.UehaT.KanemaruK.NodaK
Timing and Distribution of Protein on GLP-1 Therapy Because GLP-1 medications slow stomach emptying, spreading protein evenly across three meals (rather than front-loading it at breakfast) often feels more comfortable and reduces digestive side effects like nausea
Approach this trend with extreme caution
Luciana Agoglia, Maria Chiara Chindamo, Cristiane Villela-Nogueira World Journal of Hepatology .2025;[Epub] CrossRef Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease Mariana M Ramrez-Meja, Froylan D Martnez-Snchez, Jacqueline Crdova-Gallardo, Nahum Mndez-Snchez World Journal of Hepatology .2025;[Epub] CrossRef Association between glucose time-in-range and the severity of metabolic dysfunction-associated steatotic liver disease in Chinese adults with type 2 diabetes mellitus Chun-Hua Wang, Xuan-Yao Ji, Nian Ji, Qing-Feng Yan, Hong-Qing Xu, Xue-Qin Wang, Xiang-Fan Chen, Chun-Feng Lu BMC Endocrine Disorders .2025;[Epub] CrossRef Gut microbiota in patients with metabolic, dysfunction-associated steatotic liver disease Lissette Duarte, Fabien Magne, Martin Gotteland Current Opinion in Clinical Nutrition & Metabolic Care .2025
US$ 26.50
US$ 29.73
US$ 21.31
